Treating Diuretic Resistance: An Overview.

Abstract:

:Loop diuretics are central to the management of fluid overload in acute decompensated heart failure. However, a variance in the response to loop diuretics can alter a patient's clinical course and has an adverse effect on clinical outcomes. Thus, a diminished response to loop diuretics is an important clinical issue. Factors thought to contribute to diuretic resistance include erratic oral absorption in congested states and postdiuretic sodium retention. Further contributing to diuretic resistance in patients with advanced heart failure are decreases in renal perfusion and alterations in sodium handling that occur in an attempt to maintain circulatory homeostasis. Several pharmacologic interventions have been used to improve diuretic response. Intravenous diuretic administration, increasing diuretic doses, or changing diuretic agents can potentially overcome pharmacokinetic obstacles which contribute to drug resistance. Combination diuretic therapy may be useful to overcome increased sodium retention, dopamine may improve renal perfusion, and hypertonic saline may transiently increase intravascular volume and improve sodium delivery to the tubules of the nephron. Despite the prevalence of diuretic resistance, there remains a paucity of clinical trial evidence to help guide therapy in these patients.

journal_name

Cardiol Rev

journal_title

Cardiology in review

authors

Bowman BN,Nawarskas JJ,Anderson JR

doi

10.1097/CRD.0000000000000116

subject

Has Abstract

pub_date

2016-09-01 00:00:00

pages

256-60

issue

5

eissn

1061-5377

issn

1538-4683

journal_volume

24

pub_type

杂志文章,评审
  • Sauna as a therapeutic option for cardiovascular disease.

    abstract::The physiologic effect of the sauna in human beings has been studied extensively, but only recently have there been studies to suggest sauna can be an effective therapeutic modality for patients with cardiovascular disease, especially for those with congestive heart failure. The data reported to date have been promisi...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000124844.56479.05

    authors: Nguyen Y,Naseer N,Frishman WH

    更新日期:2004-11-01 00:00:00

  • Primary pulmonary hypertension and cor pulmonale.

    abstract::Primary pulmonary hypertension and cor pulmonale represent forms of precapillary pulmonary hypertension due to intrinsic lung disease. In the case of primary pulmonary hypertension, this is due to disease of the pulmonary vasculature while cor pulmonale is related to diseases of the pulmonary vasculature, airways, or ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200209000-00003

    authors: Lehrman S,Romano P,Frishman W,Rashid A,Dobkin J,Reichel J

    更新日期:2002-09-01 00:00:00

  • Association between Arsenic Exposure and Cardiovascular Disease.

    abstract::Arsenic is a ubiquitously dispersed metalloid that has been implicated as the cause of various adverse health effects. Human exposure to arsenic primarily occurs through contaminated drinking water and dietary intake of rice and grains, posing a great public health risk to millions of people worldwide. High levels of ...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/CRD.0000000000000357

    authors: Kononenko M,Frishman WH

    更新日期:2020-09-15 00:00:00

  • Assessment of the Patient With Intracerebral Hemorrhage: A Review of the Literature.

    abstract::Spontaneous nontraumatic intracerebral hemorrhage is associated with high morbidity and mortality. Given the risk of rapid neurological deterioration, early identification with rapid neuroimaging is vital. Predictors of outcome, such as spot sign and intracerebral hemorrhage score, can help guide management goals. Man...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/CRD.0000000000000332

    authors: Kurian C,Kaur K,Kaur G,Sahni R

    更新日期:2021-01-01 00:00:00

  • Glucose-insulin-potassium therapy in the era of coronary revascularization.

    abstract::Glucose-insulin-potassium (GIK) utilization in the treatment of acute myocardial infarction (AMI) has been studied since the early 1960s with varying results. It is well established that ischemic myocardial cells convert from aerobic metabolism of glucose to toxic anaerobic free fatty acid (FFA) metabolism for the pro...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000175287.38905.14

    authors: Leos CL,Griego JE,Anderson JR

    更新日期:2005-09-01 00:00:00

  • Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.

    abstract::The increased life expectancy of women living in industrialized countries is associated with an increase in diseases dependent or facilitated by a state of estrogen deficiency, such as cardiovascular and cerebrovascular diseases. Several studies have shown that estrogen replacement therapy reduces the occurrence of co...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200201000-00010

    authors: Rosano GM,Fini M

    更新日期:2002-01-01 00:00:00

  • Inappropriate sinus tachycardia: current therapeutic options.

    abstract::Inappropriate sinus tachycardia (IST) is an uncommon form of arrhythmia characterized by an increased heart rate that is out of proportion to a normal physiologic demand. The etiology of IST remains ill-defined and controversial. Clinical presentation of IST is highly variable, from isolated to sustained palpitations,...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e31822f0b3e

    authors: Femenía F,Baranchuk A,Morillo CA

    更新日期:2012-01-01 00:00:00

  • Care of the Post-CABG Patient.

    abstract::An estimated 400,000 coronary artery bypass graft operations are performed annually in the United States. Saphenous vein grafts are the most commonly used conduits; however, graft failure is common. In contrast, left internal mammary artery grafts have more favorable long-term patency rates. Guidelines recommend aggre...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000261

    authors: Collins D,Goldberg S

    更新日期:2020-01-01 00:00:00

  • Evacetrapib: Another CETP Inhibitor for Dyslipidemia With No Clinical Benefit.

    abstract::Evacetrapib is a cholesteryl ester transfer protein (CETP) inhibitor that has been recently studied as a cholesterol modifying agent to reduce cardiovascular risk and mortality in high risk cardiovascular disease patients. Evacetrapib acts to decrease lipid exchange through CETP inhibition. CETP acts to transfer chole...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000137

    authors: Eyvazian VA,Frishman WH

    更新日期:2017-03-01 00:00:00

  • Cardiac Resynchronization Therapy: Maximizing the Response to Biventricular Pacing.

    abstract::Cardiac resynchronization therapy (CRT) has become a mainstay therapy to improve clinical outcomes of patients with left ventricular systolic dysfunction and a wide QRS complex, in addition to guideline-directed medical therapy. As clinical experience with CRT continues to expand, the device and lead design, along wit...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000127

    authors: Ng CY,Heist EK

    更新日期:2017-01-01 00:00:00

  • Pulmonary artery hypertension: caveolin-1 and eNOS interrelationship: a new perspective.

    abstract::Pulmonary artery hypertension (PAH) is a sequela of a number of disparate diseases, often with a fatal consequence. Endothelial dysfunction is considered to be an early event during the development of PAH. Impaired availability of bioactive nitric oxide (NO) is a key underlying feature in most forms of clinical and ex...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000249381.49138.b9

    authors: Mathew R,Huang J,Gewitz MH

    更新日期:2007-05-01 00:00:00

  • Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure.

    abstract::Underlying causes, risk factors, and precipitating causes of heart failure (HF) should be treated. Drugs known to precipitate or aggravate HF such as nonsteroidal antiinflammatory drugs should be stopped. Patients with HF and a low left ventricular ejection fraction (systolic heart failure) or normal ejection fraction...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000175289.87583.e5

    authors: Aronow WS

    更新日期:2006-05-01 00:00:00

  • Ticagrelor: a novel reversible oral antiplatelet agent.

    abstract::The complex mechanism of platelet activation creates an optimal target for pharmacological treatment in patients with acute coronary syndromes. Current antiplatelet medications that are used in addition to aspirin include the thienopyridines, clopidogrel and prasugrel, but there are several limitations to the use of t...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182099d86

    authors: Nawarskas JJ,Clark SM

    更新日期:2011-03-01 00:00:00

  • Ayurveda and Yoga in Cardiovascular Diseases.

    abstract::Ayurveda is derived from 2 Sanskrit words, namely, "Ayus" and "Veda," meaning life and knowledge, respectively. It literally means science of life. Ayurveda, of which yoga is an integral part, is widely practiced in India and is gaining acceptance in many countries around the world. It is a comprehensive and a holisti...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000128730.31658.36

    authors: Mamtani R,Mamtani R

    更新日期:2004-09-01 00:00:00

  • Antiretroviral and statin drug-drug interactions.

    abstract::Patients living with the human immunodeficiency virus (HIV) are at risk for dyslipidemia as a result of the disease itself and from certain classes of antiretroviral therapy. The protease inhibitors and non-nucleoside reverse transcription inhibitors have been associated with elevated triglycerides, total, and low-den...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181903b7f

    authors: Ray GM

    更新日期:2009-01-01 00:00:00

  • Obesity and cardiovascular disease risk: research update.

    abstract::The obesity epidemic has reached unprecedented proportions in Western society. Evidence continues to accumulate that obesity is associated with significant morbidity and mortality and in particular that it is an independent risk factor for cardiovascular disease (CVD). The association of obesity with CVD and its risk ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200107000-00005

    authors: Melanson KJ,McInnis KJ,Rippe JM,Blackburn G,Wilson PF

    更新日期:2001-07-01 00:00:00

  • Contemporary in-hospital management strategies for acute decompensated heart failure.

    abstract::Acute decompensated heart failure (ADHF) is a common syndrome with diverse etiologies and precipitating factors, which is associated with significant morbidity and mortality. Tremendous resources are used in treating this syndrome, with few prospectively designed clinical trials to guide therapy. Patients suffering fr...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e318214022b

    authors: Sanchez CE,Richards DR

    更新日期:2011-05-01 00:00:00

  • A novel approach to left atrial appendage exclusion: the WATCHMAN device.

    abstract::Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181e53abb

    authors: Gorodnitskiy A,Lucariello RJ,Aizer A,Coppola JT

    更新日期:2010-09-01 00:00:00

  • Successful thrombolysis of st. Jude medical aortic prosthesis with tissue-type plasminogen activator in a pregnant woman: a case report.

    abstract::Mechanical valve thrombosis is a life-threatening event. Pregnancy is associated with a hypercoagulable state that further emphasizes the importance of adequate anticoagulation. This is associated with a therapeutic dilemma. Continued anticoagulation with warfarin throughout the first trimester can result in fetopathi...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/00045415-200211000-00007

    authors: Behrendt P,Schwartzkopff B,Perings S,Gerhardt A,Zotz RB,Strauer BE

    更新日期:2002-11-01 00:00:00

  • Cryptogenic Stroke: Making the Management Less Cryptic.

    abstract::Cryptogenic stroke (CS) accounts for 20% to 40% of ischemic strokes. CS is defined as a cortical infarct suggestive of an embolic stroke with no identifiable cardiac etiology, large vessel occlusive disease, or small vessel lacunar stroke. The likely etiologies for CS are patent foramen ovale (PFO) and paroxysmal atri...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000073

    authors: Marks SJ,Khera S

    更新日期:2016-07-01 00:00:00

  • Saphenous vein graft disease: review of pathophysiology, prevention, and treatment.

    abstract::Saphenous vein graft (SVG) disease after coronary artery bypass grafting (CABG) occurs in three phases: thrombosis, intimal hyperplasia, and atherosclerosis. Within the first month, thrombosis plays a major role. From month 1 to month 12, intimal hyperplasia occurs. Beyond 12 months, atherosclerosis becomes the primar...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182736190

    authors: Kim FY,Marhefka G,Ruggiero NJ,Adams S,Whellan DJ

    更新日期:2013-03-01 00:00:00

  • Indications for and long-term survival in patients with automatic implantable cardioverter-defibrillators.

    abstract::Automatic implantable cardioverter-defibrillators (AICDs) were implanted in 378 men and 95 women, mean age 69 +/- 12 years. At 3.6-year follow up, survival was 76% in patients who had an AICD because of cardiac arrest as a result of ventricular fibrillation or ventricular tachycardia not resulting from a transient or ...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000128728.49766.3f

    authors: Aronow WS,Sorbera C,Chagarlamudi A,Tabandeh H,Gupta S,Cohen M

    更新日期:2005-01-01 00:00:00

  • Pulmonary hypertension in pregnancy.

    abstract::The presence of pulmonary arterial hypertension (PAH) in pregnancy is rare and signifies a high-risk pregnancy. Although the majority of mothers have knowledge of their condition before pregnancy, approximately one-third of patients are diagnosed during pregnancy. Termination of pregnancy should be discussed, and is o...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e318275cf01

    authors: Martínez MV,Rutherford JD

    更新日期:2013-07-01 00:00:00

  • Radiation-induced heart disease.

    abstract::Radiation-induced heart disease (RIHD) is becoming an increasing concern for patients and clinicians alike as the use of radiation therapy for the treatment of certain malignancies increases, and patient mortality secondary to neoplasms of the thorax, in particular Hodgkin's lymphoma and breast cancer, decreases. The ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182431c23

    authors: Filopei J,Frishman W

    更新日期:2012-07-01 00:00:00

  • Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm.

    abstract::Abdominal aortic aneurysm is a multifactorial disease with genetic risk factors and an immunologic component. Immune cells, including macrophages, neutrophils, mast cells, B- and T- lymphocytes, along with vascular smooth muscle cells and adventitial fibroblasts, produce cytokines and enzymes, promoting an inflammator...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181b04698

    authors: Rizas KD,Ippagunta N,Tilson MD 3rd

    更新日期:2009-09-01 00:00:00

  • Neprilysin Inhibition and the Treatment of Heart Failure: Recent Steps in the Right Direction.

    abstract::Numerous investigators have attempted to target the natriuretic peptide system in the treatment of heart failure since it was first described over 30 years ago. The history of neprilysin inhibition as a treatment for heart failure has been characterized by numerous setbacks. Recently, the PARADIGM-HF trial has shown f...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000169

    authors: Bartell N,Frishman WH

    更新日期:2017-11-01 00:00:00

  • The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: What's New? What's Different?

    abstract::Hypertension remains a major cause of cardiovascular morbidity and mortality in the United States. Disturbing trends have been reported recently and include declining rates of successful blood pressure control and increasing rates of stroke, congestive heart failure, and hypertension-associated end-stage renal disease...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/00045415-199809000-00009

    authors: Canzanello VJ,Sheps SG

    更新日期:1998-10-01 00:00:00

  • Third-Generation LVADs: Has Anything Changed?

    abstract::The field of durable left ventricular assist devices has advanced dramatically since its introduction into the clinical realm. From the first-generation pulsatile HeartMate XVE device to the second-generation continuous axial flow HeartMate-2 to the current third-generation centrifugal flow devices, the left ventricul...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000268

    authors: Levine A,Gass A

    更新日期:2019-11-01 00:00:00

  • Implications of the New National Guidelines for Hypertension.

    abstract::Automated validated devices should be used for measuring blood pressure (BP). A systolic BP between 120 and 129 mm Hg with a diastolic BP < 80 mm Hg should be treated by lifestyle measures. Lifestyle measures plus BP lowering drugs should be used for secondary prevention of recurrent cardiovascular disease (CVD) event...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000187

    authors: Aronow WS,Frishman WH

    更新日期:2018-03-01 00:00:00

  • Antithrombotic therapy in patients with heart valve prostheses.

    abstract::Heart valve prostheses carry a risk for thrombosis and require an antithrombotic strategy to prevent stroke, systemic embolism, and prosthetic valve thrombosis. Contemporary randomized trials to guide the clinician on the optimal anticoagulant treatment are scarce, and the validity of the historical data for current r...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182638578

    authors: Hermans H,Vanassche T,Herijgers P,Meuris B,Herregods MC,Van de Werf F,Verhamme P

    更新日期:2013-01-01 00:00:00